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Introduction !
In 2050 more than 40 % of the population of Germany will be over 60 years of age, whereas in particular those over 80 years of age will increase disproportionately and could reach approx. 15 % [1]. The anticipated life expectancy of today's 60-year-old is about 85 years; today's 80-year-old can expect to live to age 89 [2] . There are some pitfalls when distinguishing physiological and pathological changes of the lung among older persons; such drawbacks are the subject of this article. Since there is no uniform definition of age [3] , persons older than 60 years of age will be arbitrarily defined here as the cohort of the "elderly". Actually this lower thresholdwhich can vary individuallycould be set at 70 or 80 years.
The following issues should be addressed: The histopathological and pulmonary changes in elderly healthy volunteer subjects have been extensively studied in recent decades [4, 5] . On the other hand, a healthy elderly norm population used for reference is rare, and the number of volunteer subjects is frequently small. Thus Bisschop et al. [6] , in their cohort of 66 to 88-year-olds for a study of pulmonary obstruction and lung function parameters, found that of their initial selection of 750 people, only 116, i. e. 15.5 % "healthy" volunteers could be identified, that is, asymptomatic non-smokers without pre-existing conditions.
Structural aspects Thoracic wall and (accessory) respiratory muscles:
With increasing age, rigidity of the thoracic wall increasesdue to calcification of costosternal joints and osteoarthritis of the costovertebral junctions on the one hand, and on the other, increasing kyphosis of the thoracic spine due to vertebral fusion. The latter also exhibits effects upon diaphragm mobility and force [4, 7, 8] , potentially causing restrictive respiratory disorders. The internal intercostal muscles which support active expiration atrophy with increasing age; expectoration consequently becomes difficult, and infectious respiratory disease is fostered. In addition, the amount of effort required by the diaphragm and abdominal muscles to effect breathing increases.
Lung parenchyma:
Lung elasticity decreases with age. This primarily affects the interconnection of elastic fibers; additionally increased release of the so-called neutrophil elastase with the destruction of elastin has been studied [4] . Ex-vivo studies on human autopsy specimens have demonstrated an increase in the size of the alveolar ducts as well as the alveoli [9]. On the other hand, the pathognomonic destruction of the alveolar walls in emphysema is not an element of the physiological aging process.
Pulmonary aspects
As elasticity of the lung diminishes, its compliance (extensibility) likewise decreases, with reduced compliance of the chest due to rigidity. Total lung capacity does not essentially change with aging. At end expiration however, residual volume increases, leading to a decline in vitality. Reduced supporting tissue surrounding the respiratory bronchioles results in significantly premature collapse or closing of the small air passages [10, 11] with air trapping as radiological correlate. A related component of the peripheral air passages is consequently not involved in gas exchange. In addition to decreased capillary density per acinus, the previously-mentioned inhomogeneity in the ventilation/perfusion ratio ensures reduced capacity for the diffusion of carbon monoxide (CO transfer factor D LCO ) [11 -13] .
Radiological Aspects
! Essentially based on radiological symptom patterns, the following discusses their implications and significant related studies.
Density reduction of lung parenchyma
Age-related hyperinflation, "senile emphysema", pulmonary emphysema and COPD in old age Physiological size increase of alveoli and alveolar ducts as a radiological correlate contrasts with the age-related density reduction of the lungs by approx. 50 HU between the ages of 20 and 70 [14] , and can hardly be differentiated visually by the investigator. At the same, the prevalence of COPD increases with age, whereas the extent of air passage obstruction and dysfunction as well as the extent of emphysema can vary according to phenotype. In their meta-analysis, Halbert et al. [15] describe a prevalence of COPD at around 15 % for those 65 years of age and older. Histological studies by Verbeken et al. [10] demonstrated that age-related alveolar hyperinflation is homogeneously distributed across the entire lung, whereas emphysematous pulmonary changes mainly affect the upper or lower lobe, depending on the phenotype. The concept "senile emphysema" describing physiological alveolar hyperinflation without destruction is considered obsolete [9, 16] . Since the presence of pulmonary emphysema represents an independent risk factor for developing lung cancer [17] , and since procedures are increasingly being used to reduce lung volume (e. g. endobronchial valves, coils), when conventional thoracic Xrays are performed, the examiner should look for typical signs of advanced pulmonary emphysema (flattening of the diaphragm, expanded retrosternal and retrocardial airspace, lung hypertransparency, peripherally rarefied vessels). For low and medium grade emphysematous changes, HRCT is clearly superior to conventional X-ray imaging [18] . In addition to visual emphysema grading as described by Bankier et al. [19] , quantitative methods particularly demonstrate high correlation with pulmonary parameters [20] . These offer measurement during inspiration (extent of emphysema) as well as expiration (air trapping as correlate of the extent of air passage obstruction). Coronal and sagittal minimum intensity projections (MinIP) are recommended for orientation purposes. • " Fig. 1 shows bullous pulmonary emphysema with UIP pattern with suspected coincidental idiopathic pulmonary fibrosis.
Density increase of lung parenchyma
A typical finding in thoracic CT, particularly in the aged, is reversible, relatively homogeneous ground glass opacity in the basal dependent regions of the lung ( • " Fig. 2 ). Shallow inspiration depth and position-dependent (hypostatic) alteration of the parenchyma are common causes. Practical note If there is clinical suspicion of interstitial pulmonary disease (see section 2.5) and the CT reveals density increases in the dependent lung regions, supplementary sequential layer images should be obtained in the prone position in order to determine reversibility of the density increases as an indication of hypostasis. If ground glass changes persist in the prone position, and additional signs of fibrosis such as honeycombing or tractive bronchiectasis are present, then usual interstitial pneumonia (UIP) should be consid-ered, e. g. in cases of idiopathic pulmonary fibrosis or associated pulmonary alterations; however, consideration should likewise be given to non-specific interstitial pneumonia (NSIP) such as appears in cases of collagenosis, but also occurring idiopathically. NSIP can also be manifested as diffuse subpleural ground glass without indication of fibrosis. The so-called mosaic pattern, qualitatively recognizable focal pulmonary parenchymal density differences during inspiration is frequently limited to the secondary lobule or air trapping during expiration, with a lack of density increase of lung tissue due to retained air. This is a common finding in aging patients, but may also be an expression of manifest pulmonary disease. Lee et. al [21] showed that in an asymptomatic cohort ≥ 61 years of age (N = 17), the portion of subjects with air trapping was 76 %. Misdiagnosis of a mosaic pattern or even generalized "alveolitis"-related ground glass may be the result of accidental images of expiration or respiration due to limited patient cooperation during the examination, particularly during sequential HR imaging.
Incidental pulmonary nodules: solid, partially solid, ground glass
The increasing number of lung cancer screening studies in the 1990 s was accompanied by the recognition of the prevalence of incidentally-detected pulmonary nodules (or nodular shadows) among asymptomatic volunteer subjects, mainly smokers or former smokers between the ages of 55 and 75. The proportion of CT scans detecting at least one non-calcified nodule ranges from approx. 25 % [22] to approx. 70 % [23] . In the course of further invasive diagnosis only 1 % of detected nodules were found to be malignant. 80 % of the malignoma were larger than 8 mm. The Fleischner Society established recommendation for the management of pulmonary nodules based on the size and risk stratification of nodules found in volunteer subjects. In addition, algorithms were established for subsolid nodules and ground glass nodules [24, 25] . There is no evidence to support a different procedure among very old subjects (> 75 years). Further, geographic and environmental factors have been insufficiently included in the risk stratification.
• " Fig. 3 shows a focal ground glass lesion and a solid pulmonary nodule. In the future, low-dose screening CT, using visual and quantitative methods, could be employed to detect the presence of pulmonary emphysema and early forms of interstitial pulmonary disease [26] .
Changes to the airways
Matsuoka et al. [27] showed a significant relationship between aging and the ratio of the diameter of the bronchus to the accompanying artery (bronchoarterial ratio). This was explained by relative hypoxemia existing in an aged cohort which caused vasoconstriction and (relative) bronchial dilation, effects which are seen among populations living at high altitude. In Matsuoka's cohort (age: 73.6 ± 6.2 years, N = 27), the bronchoarterial ratio among 41 % of subjects was greater than 1. Practical note Caution should be observed with respect to a hasty diagnosis of bronchiectasis in the elderly. Additional criteria for diagnosis of bronchiectasis should include a bronchoarterial ratio greater than 1.5, bronchi visible into the direct periphery and lack of distal tapering of the bronchial diameter. In addition, complications of bronchiectasis such as exudative bronchiolitis and mucus retention are further evidence. Systemic diseases such as rheumatoid arthritis or chronic inflammatory bowel disease frequently coincidentally exhibit changes in the airways. The diagnosis report of elderly patients with only discretely expanded bronchial diameter without additional signs of bronchiectasis should document this (e. g. "borderline dilated bronchial system"). The degree of inspiration influences this, on the peripheral airways in particular [28] . The diagnosis of bronchial wall thickening using HRCT can only be passably judged. As a consequence of chronic airway disease, it is difficult to distinguish bronchial wall thickening from peribronchial cuffing, i. e. thickening of the bronchial sleeves, in a conventional radiograph such as of blockage of the pulmonary vein due to heart failure. A volume CT with secondary calculated HR slices is preferred to clarify possible bronchiectasis in the elderly. Coronal minimum-intensity projections (MinIPs) used for secondary reformatting disclose more discrete findings ( • " Fig. 4 ).
Interstitial lung abnormalitiesincidental findings without disease or subclinical ILD?
Utilization of new substances such as pirfenidone when treating low-to-mid-grade idiopathic pulmonary fibrosis (IPF) increases the importance of early diagnosis of IPF within the "therapeutic window". This places HRCT of the lung in a position of prominence [29] in order to identify patients exhibiting interstitial pulmonary alterations following a possible or established UIP pattern. Algorithms for screening an IPFa combination of clinical signs (e. g. auscultatory crepitation, persistent cough, dyspnea) and HRCT-are currently the subject of prospective studies [26, 30] . In secondary analyses of large-scale lung cancer screening programs, such as the American National Lung Screening Trial (NLST), using an age cohort of 55 to 74-year-olds, it has been shown that interstitial, non-nodular changes occur in about 10 % of cases, whereas non-fibrotic changes appear in approx. 6 % of cases (i. e. ground glass, mosaic pattern, consolidation). Fibrotic changes occur at a rate of 2 % (i. e. ground glass and septum thickening, septum thickening only, honeycombing); mixed fibrotic/non-fibrotic findings occur in approx. 2 % of cases [31, 32] . Typically the screening trials include smokers and former smokers, but not those who have never smoked (i. e. non-smokers). There is no empirical data on very old subjects (> 80 years). Only Copley et. al [33] reported incidental pulmonary HRCT findings in a small cohort (age 80.6 ± 4.2, N = 40) of non-smokers. All scans were performed in the prone position: predominantly subpleural and basal reticular thickening (septum thickening) was evident in 60 % of the group of above-75-year-olds; isolated pulmonary cystic lesions were detected in 25 % of the age group. The absence of ground glass lesions was striking, possibly due to an optimized protocol in the prone position to exclude effects of hypostasis. A histopathological correlation with the radiological findings could not be made, since no assertion could be made regarding the proportion of early forms of e. g. IPF. The majority of subjects exhibited unremarkable, i. e. ageappropriate, results in the pulmonary function test. The differentiation of the described septum thickening from early forms of IPF and other forms of interstitial lung disease (ILD) is both elementaryand highly challenging [34] ( • " Fig. 5 ). A frequent finding in the elderly includes focal interstitial thickening adjoining osteophytes of the thoracic spine discovered in approx. 45 % of cases [35] ( • " Fig. 6 ).
Frequently pharmaceutically-associated ILD must be considered. Despite numerous studies [36, 37] and a few internet databases (e. g. http://www.pneumotox.com), it is still difficult to make a coincidental or even causal correlation with a specific noxa ( • " Fig. 7) . The interaction of polypharmacydefined as regular intake of four or more medicationson the lung and its radiological correlates is still not considered. In practice, particularly with geriatric patients with comorbidities and multiple medications, narrowing down to a sole diagnosis of "medication-induced ILD" is rarely possible. Brief follow-ups using chest images, especially using a few sequential HR layers with acceptable radiation exposure can favor limiting differential diagnosis to The suspected diagnosis of chronic hypersensitivity pneumonitis was not supported by BAL and history. There were comorbidities with chronic left ventricular dysfunction and gastroesophageal reflux. Polypharmacy without higher grade 'suspicious' drugs. The differential diagnosis favored a mixed pattern due to uncharacteristic pulmonary fibrosis and chronic pulmonary venous congestion. Forced invasive clarification was omitted due to age and lung functional limitation. a few possibilities ( • " Fig. 7, 8) . Camus et al. [37] identify a variety of drugs that frequently induce ILD, including amiodarone, antibiotics (especially nitrofurantoin), nonsteroidal antiphlogistics, chemotherapeutics (bleomycin, cyclophosphamide, gemicitabine, docetaxel, methotrexate). There are no data regarding the prevalence of pulmonary toxicity of medications most frequently prescribed to the elderly and their radiological manifestation.
Recommendations for Differential Diagnosis of the Thorax in the Elderly -Perspectives on Thoracic Imaging of Elderly Patients and the Limits of Evidence
! This exposition has not identified the numerous "border areas" of imaging of the aging heart and vascular system. Also excluded are the descriptions of manifest disorders beyond the border area: pulmonary infectious diseases in old age, lung cancer and other pulmonary malignancies, pleural lesions, pulmonary thromboembolisms as well as pulmonary hypertension.
• " Fig. 9 again summarizes essential alterations to the geriatric thorax and visible in thoracic CT and provides diagnostic support for the gradual escalation of radiological diagnosis of the elderly. In order to obtain our own results for age-specific pulmonary changes, thoracic CT scans performed consecutively between May and September 2014 in our Radiology Department in a basic and standard care hospital were retrospectively evaluated. Two cohorts (age ≤ 50 years ["young"] vs, ≥ 80 years ["old"] with 29/30 volunteer subjects were compared: "young" cohort (average age 40. • " Table 1 shows the frequency of pulmonary findings of our cursory study related to the "young" and "old" cohorts. HRCT of the lung of a 70-year-old patient with seropositive rheumatoid arthritis during treatment with methotrexate and leflunomide: a with discrete uncharacteristic fibrosis alterations (white arrow), b four weeks later with clinical deterioration with rapid increasing ground-glass and septal thickening, in the BAL marked lymphocytosis, severe loss of diffusion capacity, c 3 months later after steroid therapy and cessation of MTX and leflunomide with decline in ground-glass, but increased traction bronchiectasis (black arrow). The differential diagnosis was a mixed pattern of drug-induced ILD and acute exacerbation of an uncharacteristic pre-existing pulmonary fibrosis due to rheumatoid arthritis. ▶ Classification of pulmonary changes caused by drugrelated influences, systemic disorders and certain past events (e. g. myocardial infarction, previous pneumonia) can be made by correlating with closely-monitored radiological vital signs. Table 1 Results of our retrospective study of radiological changes in thoracic CT differentiated by collective "young" (≤ 50 years) vs. "old" (≥ 80 years) and the preliminary radiological diagnoses according to categories. 
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